Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Sundaram · SciRah

Researcher profile · Semantic Scholar

S. Sundaram

Share profile

S. Sundaram — researcher profile on SciRah

h-index: 17
Works: 77
Citations: 1,623

Most-cited papers

Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
A. Mato, N. Shah, W. Jurczak, Che-Ah Y. Chan +40 more
2021The Lancet374 citations Open access
Semantic Scholar
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
A. Mato, L. Roeker, N. Lamanna, J. Allan +58 more
2020Blood296 citations Open access
Semantic Scholar
NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 4.2020
W. Wierda, J. Byrd, J. Abramson, S. Bilgrami +26 more
2020109 citations
Semantic Scholar
Burkitt Lymphoma in the Modern Era: Real World Outcomes and Prognostication Across 30 US Cancer Centers.
A. Evens, A. Danilov, D. Jagadeesh, Amy Sperling +54 more
2020Blood106 citations Open access
Semantic Scholar
Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell–directed therapies
P. Ghione, Juan J. Gu, K. Attwood, P. Torka +18 more
2021Blood98 citations Open access
Semantic Scholar
Burkitt Lymphoma International Prognostic Index.
A. Olszewski, L. Jakobsen, G. Collins, K. Cwynarski +45 more
2021Journal of Clinical Oncology64 citations Open access
Semantic Scholar
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies
L. Roeker, T. Eyre, Meghan C. Thompson, N. Lamanna +48 more
2021Blood62 citations Open access
Semantic Scholar
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.
J. Alderuccio, A. Olszewski, A. Evens, G. Collins +55 more
2021Blood Advances44 citations Open access
Semantic Scholar
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab.
Taylor R. Brooks, E. Zabor, Yohanna B. Bedelu, Xi Yang +41 more
2025Blood43 citations
Semantic Scholar
Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature.
Housam Haddad, S. Sundaram, C. Magro, U. Gergis
2014Hematology/Oncology and Stem Cell Therapy41 citations Open access
Semantic Scholar
Outcomes of patients with limited-stage aggressive large B-cell lymphoma with high-risk cytogenetics.
P. Torka, S. Kothari, S. Sundaram, Shao-Ying Li +28 more
2020Blood Advances39 citations Open access
Semantic Scholar
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study
A. Zayac, A. Evens, A. Danilov, Stephen D. Smith +53 more
2021Haematologica38 citations Open access
Semantic Scholar
Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma
Anil R. Singh, Juan J. Gu, Qunling Zhang, P. Torka +3 more
2020Cancer & Metabolism33 citations Open access
Semantic Scholar
High-grade B-cell lymphoma, not otherwise specified: a multi-institutional retrospective study
A. Zayac, D. Landsburg, Mitchell E Hughes, Allison M. Bock +36 more
2023Blood Advances29 citations Open access
Semantic Scholar
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers
K. David, S. Sundaram, Seo-Hyun Kim, R. Vaca +42 more
2023American journal of hematology/oncology27 citations Open access
Semantic Scholar
Aggressive lymphoma subtype is a risk factor for venous thrombosis. Development of lymphoma ‐ specific venous thrombosis prediction models
G. Dharmavaram, S. Cao, S. Sundaram, S. Ayyappan +11 more
2020American journal of hematology/oncology23 citations Open access
Semantic Scholar
Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes
Charlotte B Wagner, K. Boucher, A. Nedved, I. Micallef +26 more
2023Haematologica19 citations Open access
Semantic Scholar
Safety and Efficacy of Tenalisib Given in Combination with Romidepsin in Patients with Relapsed/Refractory T-Cell Lymphoma: Final Results from a Phase I/II Open Label Multi-Center Study
S. Iyer, A. Huen, Wei-Yun Z. Ai, D. Jagadeesh +13 more
2021Blood17 citations Open access
Semantic Scholar
Pirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Updated Results from the Phase 1/2 BRUIN Study
A. Mato, J. Pagel, Catherine C. Coombs, N. Shah +33 more
2021Blood14 citations Open access
Semantic Scholar
FDG PET imaging in multiple myeloma: implications for response assessments in clinical trials.
S. Sundaram, James J. Driscoll, M. Fernández-Ulloa, M. D. De Lima +1 more
2018American Journal of Nuclear Medicine and Molecular Imaging14 citations
Semantic Scholar
Real-World Outcomes with Bispecific T-Cell Engagers (REALBiTE) for Relapsed or Refractory Large B-Cell Lymphoma: A Multi-Center, Retrospective Cohort Study
T. Brooks, E. Zabor, Yohana B. Bedelu, Nikita K Dave +39 more
2024Blood13 citations
Semantic Scholar
Pirtobrutinib, A Next Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results from the Phase 1/2 BRUIN Study
Michael L. Wang, N. Shah, A. Alencar, J. Gerson +31 more
2021Blood13 citations Open access
Semantic Scholar
Outcomes of Patients with Newly-Diagnosed Burkitt Lymphoma (BL) and Central Nervous System (CNS) Involvement Treated in the Modern Era: A Multi-Institutional Real-World Analysis
A. Zayac, A. Evens, A. Stadnik, Stephen D. Smith +48 more
2019Blood13 citations Open access
Semantic Scholar
Pevonedistat, a NEDD8-Activating Enzyme Inhibitor, Induces Apoptosis and Augments Efficacy of Chemotherapy and Small Molecule Inhibitors in Pre-clinical Models of Diffuse Large B-cell Lymphoma
P. Torka, C. Mavis, S. Kothari, S. Belliotti +4 more
2020eJHaem10 citations Open access
Semantic Scholar
Carfilzomib combined with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory DLBCL
P. Torka, A. Groman, J. Wong, J. Nichols +18 more
2022Blood Advances8 citations Open access
Semantic Scholar
Oral Abstract: MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study
Jonathon B. Cohen, N. Shah, A. Alencar, J. Gerson +31 more
2022Clinical Lymphoma, Myeloma & Leukemia8 citations
Semantic Scholar
Utility of Bone Marrow Aspirate and Biopsy in Staging of Patients with T-Cell Lymphoma in the PET-Era – Tissue Remains the Issue
S. Sundaram, Mazen Jizzini, D. Lamonica, K. Attwood +3 more
2020Leukemia and Lymphoma8 citations Open access
Semantic Scholar
EBV-positive PCNSL in older patients: incidence, characteristics, tumor pathology, and outcomes across a large multicenter cohort
Prashasti Agrawal, K. David, Zheng-Ming Chen, S. Sundaram +47 more
2023Leukemia and Lymphoma6 citations
Semantic Scholar
Worldwide Examination of Patients with CLL Hospitalized for COVID-19
L. Roeker, L. Scarfò, T. Chatzikonstantinou, P. Abrisqueta +149 more
2020Blood6 citations Open access
Semantic Scholar
BRD4 Inhibitors Enhance the Anti-Tumor Activity of Targeted Therapy in Chronic Lymphocytic Leukemia
S. Sundaram, C. Mavis, Juan J. Gu, P. Torka +1 more
20205 citations Open access
Semantic Scholar
Ofatumumab plus HyperCVAD/HD-MA Induction Leads to High Rates of Minimal Residual Disease (MRD) Negativity in Patients with Newly Diagnosed Mantle Cell Lymphoma, Results of a Phase 2 Study
P. Torka, O. Akhtar, N. Reddy, B. Baysal +22 more
2022Cancer4 citations Open access
Semantic Scholar
Diffuse large B-Cell lymphoma associated with paraneoplastic Guillain-Barré syndrome: A diagnostic and therapeutic challenge.
Brototo Deb, M. Pandey, P. Torka, S. Sundaram
2020Hematology/Oncology and Stem Cell Therapy4 citations Open access
Semantic Scholar
Prognostication, Survival and Treatment-Related Outcomes in HIV-Associated Burkitt Lymphoma (HIV-BL): A US and UK Collaborative Analysis
J. Alderuccio, A. Olszewski, A. Evens, G. Collins +55 more
20204 citations Open access
Semantic Scholar
High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series
N. Epperla, A. Zayac, D. Landsburg, Allison M. Bock +30 more
2024Blood Advances3 citations Open access
Semantic Scholar
CLL-120 Pirtobrutinib, A Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated CLL/SLL: Updated Results from the Phase 1/2 BRUIN Study.
Catherine C. Coombs, J. Pagel, N. Shah, N. Lamanna +33 more
2022Clinical Lymphoma, Myeloma & Leukemia3 citations
Semantic Scholar
High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Central Nervous System (CNS) Involvement, Prophylaxis, and Recurrence Risk in a Multi-Institutional Series
N. Epperla, A. Zayac, D. Landsburg, Mitchell E Hughes +36 more
2022Blood3 citations
Semantic Scholar
The Evaluation and Treatment (Tx) of Burkitt Lymphoma (BL) in the Modern Era: Real World (RW) Outcomes and Prognostication across 26 US Cancer Centers (CC)
A. Evens, A. Danilov, D. Jagadeesh, Amy Sperling +49 more
2019Blood3 citations Open access
Semantic Scholar
Targeted BET inhibition with OPN-51107 synergizes with venetoclax in chronic lymphocytic leukemia
K. Zablonski, Sydney A Skupa, Alexandria P Eiken, S. Sundaram +6 more
2024Leukemia and Lymphoma2 citations
Semantic Scholar
The Burkitt Lymphoma International Prognostic Index (BL-IPI)
A. Olszewski, L. Jakobsen, G. Collins, K. Cwynarski +45 more
20202 citations Open access
Semantic Scholar
Utility of Bone Marrow Biopsy in the Staging of T-Cell Lymphoma in the PET-CT Era
S. Sundaram, Matthew Gravina, K. Attwood, F. Hernandez-Ilizaliturri +1 more
2019Blood2 citations Open access
Semantic Scholar
Bone Marrow Structure and Marrow Aspiration, Biopsy, and Collection for Therapeutic Intent Procedures
H. Meyerson, S. Sundaram, H. Lazarus
2018Concise Guide to Hematology2 citations
Semantic Scholar
Early Cardiovascular Toxicity with Treatment of Follicular Lymphoma Is Associated with Shorter Overall Survival
S. Sundaram, G. Dharmavaram, B. Tomlinson, R. Creger +6 more
20172 citations
Semantic Scholar
P1079: COMPARISON OF NOVEL SALVAGE REGIMENS AND TRADITIONAL SALVAGE CHEMOTHERAPY IN RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA
D. Ermann, V. Vardell, E. Zacholski, A. Fegley +20 more
2022HemaSphere1 citations Open access
Semantic Scholar
Real World Outcomes of Brentuximab Vedotin Maintenance after Autologous Stem Cell Transplant in Relapsed/Refractory Classical Hodgkin Lymphoma: An Time-Variable Analysis of the Effect of Dose on Progression Free Survival
Charlotte B. Wagner, D. Ermann, K. Boucher, A. Nedved +26 more
2022Blood1 citations Open access
Semantic Scholar
OLDER PATIENTS WITH PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL): REAL WORLD (RW) OUTCOMES OF POST‐INDUCTION THERAPY IN THE MODERN ERA
K. David, S. Sundaram, S.-H. Kim, R. Vaca +40 more
2021Hematological Oncology1 citations Open access
Semantic Scholar
A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy
Y. Choi, J. Caro, Xiaochun Li, Arshed Al-Obeidi +18 more
2021Blood1 citations Open access
Semantic Scholar
High-Grade B-Cell Lymphoma, Not Otherwise Specified (HGBL, NOS): Characteristics, Treatment, and Outcomes from 17 Academic US Centers
A. Zayac, D. Landsburg, Mitchell E Hughes, E. Ayers +30 more
2021Blood1 citations Open access
Semantic Scholar
Evaluating the role of baseline geriatric assessment in predicting adherence to oral targeted therapies and outcomes in older adults with non-Hodgkin lymphoma.
O. Akhtar, D. Carozza, T. Wildes, Shilpa M. Chowdhry +5 more
20211 citations
Semantic Scholar
Determinants of COVID-19 Vaccine Response in Patients with Lymphoma on B Cell Directed Therapy
Shipra Goel, Juan J. Gu, P. Torka, C. Mavis +9 more
2021Blood1 citations Open access
Semantic Scholar
Successful use of venetoclax for treatment of eosinophilic dermatosis of myeloproliferative disease in a patient with chronic lymphocytic leukemia
Gopisree Peringeth, S. Sundaram, P. Bogner, E. Conroy +1 more
2020Annals of Hematology1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Torka×24
Invite
P. Torka — researcher profile on SciRah
M. Kamdar×18
Invite
M. Kamdar — researcher profile on SciRah
D. Bond×15
Invite
D. Bond — researcher profile on SciRah
Reem Karmali×15
Invite
Reem Karmali — researcher profile on SciRah

×15

Invite

A. Zayac — researcher profile on SciRah

F. Hernandez-Ilizaliturri×15

Invite

F. Hernandez-Ilizaliturri — researcher profile on SciRah

Invite

N. Epperla — researcher profile on SciRah

Invite

N. Reddy — researcher profile on SciRah

Invite

C. Portell — researcher profile on SciRah

Invite

A. Evens — researcher profile on SciRah

D. Jagadeesh×11

Invite

D. Jagadeesh — researcher profile on SciRah

Invite

P. Martin — researcher profile on SciRah